References
- Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi:10.1164/rccm.200604-571ST17277290
- Lee MR, Sheng WH, Hung CC, Yu C-J, Lee L-N, Hsueh P-R. Mycobacterium abscessus complex infections in humans. Emerg Infect Dis. 2015;21(9):1638–1646. doi:10.3201/2109.14163426295364
- Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis. 1993;147(5):1271–1278. doi:10.1164/ajrccm/147.5.12718484642
- Epson E, Cassidy M, Marshall-Olson A, Hedberg K, Winthrop KL. Patients with nontuberculous mycobacteria: comparison of updated and previous diagnostic criteria for lung disease. Diagn Microbiol Infect Dis. 2012;74(1):98–100. doi:10.1016/j.diagmicrobio.2012.05.03522795963
- Nolt D, Michaels MG, Wald ER. Intrathoracic disease from nontuberculous mycobacteria in children: two cases and a review of the literature. Pediatrics. 2003;112(5):e434. doi:10.1542/peds.112.5.e43414595089
- Chinese Medical Association Tuberculosis Branch. Expert consensus on diagnosis and treatment of NTM diseases. Chin J Tuberc Respir Dis. 2012;35(8):572–579.
- Lopez-Varela E, Garcia-Basteiro AL, Santiago B, et al. Non-tuberculous mycobacteria in children: muddying the waters of tuberculosis diagnosis. Lancet Respir Med. 2015;3(3):244–256. doi:10.1016/S2213-2600(15)00062-425773213
- Do PC, Nussbaum E, Moua J, Chin T, Randhawa I. Clinical significance of respiratory isolates for mycobacterium abscessus complex from pediatric patients. Pediatr Pulmonol. 2013;48(5):470–480. doi:10.1002/ppul.2263822833551
- Freeman AF, Olivier KN, Rubio TT, et al. Intrathoracic nontuberculous mycobacterial infections in otherwise healthy children. Pediatr Pulmonol. 2009;44(11):1051–1056. doi:10.1002/ppul.2106919824053
- Floto RA, Olivier KN, Saiman L, et al. US cystic fibrosis foundation and european cystic fibrosis society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016;71(Suppl 1):i1–i22. doi:10.1136/thoraxjnl-2015-20736026666259
- Han D, Lee KS, Koh WJ, Yi CA, Kim TS, Kwon OJ. Radiographic and CT findings of nontuberculous mycobacterial pulmonary infection caused by mycobacterium abscessus complex. Am J Roentgenol. 2003;181(2):513–517. doi:10.2214/ajr.181.2.181051312876037
- Cystic Fibrosis Foundation. Nontuberculous mycobacteria clinical care guidelines. Available from: https://www.cff.org/Care/Clinical-Care-Guidelines/Infection-Prevention-and-Control-Clinical-Care-Guidelines/NTM-Guidelines/. Accessed 1020, 2017.
- Koh WJ, Stout JE, Yew WW. Advances in the management of pulmonary disease due to mycobacterium abscessus complex. Int J Tuberc Lung Dis. 2014;18(10):1141–1148. doi:10.5588/ijtld.14.013425216826
- Koh WJ, Jeong BH, Kim SY, et al. Mycobacterial characteristics and treatment outcomes in mycobacterium abscessus lung disease. Clin Infect Dis. 2017;64(3):309–316. doi:10.1093/cid/ciw72428011608
- Sabin AP, Ferrieri P, Kline S. Mycobacterium abscessus complex infections in children: a review. Curr Infect Dis Rep. 2017;19(11):46. doi:10.1007/s11908-017-0597-228983867
- Ryan K, Byrd TF. Mycobacterium abscessus: shapeshifter of the mycobacterial world. Front Microbiol. 2018;9:2642. doi:10.3389/fmicb.2018.0264230443245
- Bernut A, Herrmann JL, Ordway D, Kremer L. The diverse cellular and animal models to decipher the physiopathological traits of mycobacterium abscessus infection. Front Cell Infect Microbiol. 2017;7:100. doi:10.3389/fcimb.2017.0051728421165
- Ripoll F, Pasek S, Schenowitz C, et al. Non mycobacterial virulence genes in the genome of the emerging pathogen mycobacterium abscessus. PLoS One. 2009;4(6):e5660. doi:10.1371/journal.pone.000566019543527
- Lamb GS, Starke JR. Mycobacterium abscessus complex infections in children: a review of current literature. J Pediatric Infect Dis Soc. 2018;7(3):e131–e144. doi:10.1093/jpids/piy04729897511
- Jeon K, Kwon OJ, Lee NY, et al. Antibiotic treatment of mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med. 2009;180(9):896–902. doi:10.1164/rccm.200905-0704OC19661243
- Harada T, Akiyama Y, Kurashima A, et al. Clinical and microbiological differences between mycobacterium abscessus and mycobacterium massiliense lung diseases. J Clin Microbiol. 2012;50(11):3556–3561. doi:10.1128/JCM.01175-1222915613
- Koh WJ, Jeon K, Lee NY, et al. Clinical significance of differentiation of mycobacterium massiliense from mycobacterium abscessus. Am J Respir Crit Care Med. 2011;183(3):405–410. doi:10.1164/rccm.201003-0395OC20833823
- Choi GE, Shin SJ, Won CJ, et al. Macrolide treatment for mycobacterium abscessus and mycobacterium massiliense infection and inducible resistance. Am J Respir Crit Care Med. 2012;186(9):917–925. doi:10.1164/rccm.201111-2005OC22878281
- Lamb GS, Del Valle Mojica C, Srinivas N, et al. Central nervous system infections caused by mycobacterium abscessus: ventricular shunt infection in two pediatric patients and literature review. Pediatr Infect Dis J. 2018. doi:10.1097/INF.0000000000002146
- Story-Roller E, Maggioncalda EC, Cohen KA, Lamichhane G. Mycobacterium abscessus and β-lactams: emerging insights and potential opportunities. Front Microbiol. 2018;9:2273. doi:10.3389/fmicb.2018.0227330319581
- Lavollay M, Dubée V, Heym B, et al. In vitro activity of cefoxitin and imipenem against mycobacterium abscessus complex. Clin Microbiol Infect. 2014;20(5):O297–O300. doi:10.1111/1469-0691.1240524112243